Objective-Bcl-x is the most abundantly expressed member of the Bcl-2 gene family in macrophages, but its role in macrophage apoptosis during atherogenesis is unknown. Methods and Results-We previously reported dual pro-and antiatherogenic effects of macrophage survival in early versus advanced atherosclerotic lesions, respectively, potentially reflecting growing impairment of efferocytosis during plaque progression. Here, we specifically inactivated Bcl-x in macrophages and evaluated its impact on atherosclerotic lesion formation in Apoe 2/2 mice at various stages of the disease. Bcl-x deficiency in macrophages increased their susceptibility to apoptosis, resulting in the depletion of tissue macrophages in vivo, including its major pool, Küppfer cells in the liver. We also observed increased cholesterol levels that were, however, not associated with any acceleration of early atherosclerotic plaque progression. This observation suggests that the atheroprotective effect of macrophage apoptosis at that stage of disease was counterbalanced by enhanced cholesterol levels. Bcl-x KO mac /Apoe 2/2 mice exhibited significantly larger advanced lesions than control mice. These lesions showed vulnerable traits. Such enhanced lesion size may occur as a result not only of apoptotic cell accumulation but also of elevated cholesterol levels. Conclusion-Modulation of macrophage resistance to apoptosis through targeted deletion of Bcl-x has a major impact on the entire macrophage cell population in the body, including Küpffer cells. Macrophage survival may, therefore, not only influence atherosclerotic plaque development and vulnerability but also cholesterol metabolism. (Arterioscler Thromb Vasc Biol . 2012;32:1142-1149 .)
C hronic inflammation of the arterial wall is a fundamental feature of atherosclerosis and is characterized by the accumulation of LDL and immune cells driving both innate and adaptive immunity. 1 Monocytes that have been attracted to the inflamed vessel differentiate into macrophages, the major cell type found within atherosclerotic lesions. These macrophages then gorge themselves on cholesterol derived from modified LDL, which they esterify to neutralize the potentially cytotoxic and proapoptotic effects of free cholesterol. 2 However, the accumulation of proinflammatory, prooxidizing, and proapoptotic stimuli favors macrophage death, the formation of apoptotic debris, and supports necrotic core growth. 3 This, in turn, may promote plaque disruption and severe thrombotic events. 4, 5 In support of this hypothesis, experimental evidence shows that vulnerable, necrotic plaques display increased macrophage apoptosis. 6, 7 Given the potential consequences of macrophage apoptosis in advanced atherosclerotic lesions, determining the molecular mechanisms of macrophage death in advanced lesions is therefore a critical goal.
Macrophage death occurs at all stages of disease development. 8 However, it has been suggested that macrophage apoptosis may have a different impact on plaque progression depending on the stage of lesion development during which it occurs. 9, 10 Accordingly, in vivo studies have shown that disruption of the gene coding for the proapoptotic molecule Bax resulted in an increase in early atherosclerotic lesions. 11 It was also shown that disruption of the antiapoptotic factor AIM attenuated early plaque formation. 12 Our previous studies in which macrophage resistance to apoptosis was
Bcl-x inactivation in Macrophages accelerates Progression
of advanced atherosclerotic Lesions in apoe 2/2 Mice enhanced using macrophage-specific human Bcl-2 overexpression, have also shown accelerated early plaque development. 13 However, enhanced macrophage survival delayed advanced plaque progression, whereas chronic induction of apoptosis in established lesions resulted in the accumulation of apoptotic cells in advanced lesions and enhanced plaque progression. 13 The relative level of expression of proapoptotic (eg, Bax and Bak) and antiapoptotic (eg, Bcl-2 and Bcl-x) proteins of the Bcl-2 family determines the overall sensitivity of a cell to apoptotic stimuli. 14 In macrophages from atherosclerotic lesions there is essentially a complete lack of Bcl-2 and little Bcl-x. [15] [16] [17] There are also increased levels of the proapoptotic proteins Bad and Bax. [15] [16] [17] Cell culture studies have shown that Bcl-2 and Bcl-x may be involved in the protection of macrophages against apoptosis. [18] [19] [20] [21] However, 1 study evaluated the in vivo implication of Bcl-2 in the survival of macrophages and its consequences in atherosclerosis. 22 In this study, deletion of the floxed Bcl-2 gene was mediated by Cre recombinase under the control of the Lysozyme M gene, resulting in the deletion of Bcl-2 in differentiated macrophages, including those present in atherosclerotic lesions. 22 As Bcl-x may represent an alternative pathway to control macrophage survival, we chose to specifically investigate the impact of Bcl-x deficiency on plaque progression. We evaluated the impact of Bcl-x deletion both at early and advanced stages of the disease as apoptosis exerts different effects on atherogenesis as a function of lesion stage. 9, 13 We addressed the question of the impact of macrophage Bcl-x on atherosclerotic lesion formation by crossing conditional Apoe 2/2 / Bcl-x-floxed mice with Apoe 2/2 /LysM Cre mice. Using this model, we provide evidence that Bcl-x expression by macrophages plays an important protective role against apoptosis as its disruption resulted in reduction in these cells in tissues, in elevation in plasma cholesterol levels and in larger and more complicated advanced atherosclerotic lesions.
Materials and Methods

Generation of Bcl-x flox/flox -LysM-Cre Mice
The floxed Bcl-x mice of mixed genetic background 129SvEv/ C57BL6 were obtained from Dr. Edmund B. Rucker (University of Missouri, Columbia). 23 LysM-Cre mice in which Cre recombinase expression is driven by the lysozyme M promoter via gene targeting into the endogenous lysozyme M locus 24 were obtained from the Jackson Laboratory (Stock Number: 004781; backcrossed 6 times in C57BL6 genetic background). Eight crossings of Bcl-x flox/flox mice with LysM Cre/Cre mice and backcrossings with Apoe 2/2 mice resulted in an almost pure C57BL/6 genetic background (99.65% pure). For the studies described herein, Bcl-x flox/flox /LysM Cre/1 /Apoe 2/2 were used as macrophage Bcl-x deficient ( Bcl-x KO Mac /Apoe 2/2) mice whereas Bcl-x flox/flox /Apoe 2/2 , LysM Cre/1 /Apoe 2/2 , and Apoe 2/2 were used as control mice.
atherosclerosis studies
To assess the impact of macrophage Bcl-x on atherosclerosis progression, 7-week-old Bcl-x KO Mac /Apoe 2/2 , Bcl-x flox/flox /Apoe 2/2 , LysM Cre/1 /Apoe 2/2 and Apoe 2/2 mice were fed a 1%-cholesterol rich diet (Harlan Teklad, TD97131) for 10 weeks or a Western diet consisting of 0.15% cholesterol and 20% saturated fat (SAFE, France) for 10 or 27 weeks.
Plasma lipid analyses, quantification of atherosclerotic lesions, TUNEL staining, immunohistochemistry, analysis of gene expression by Q-PCR, isolation of liver leukocytes and of peritoneal macrophages, flow cytometry, and generation of bone marrow-derived macrophages (BMDM). All these procedures were performed as previously described 13, [25] [26] [27] and are detailed in the Methods section in the online-only Data Supplement.
statistical analysis
Statistical calculations were performed using GraphPad Prism, version 4.03. Results were analyzed by Student's unpaired t-tests with Welch's correction if variances were unequal. P0.05 was considered significant.
results
Generation and Characterization of Macrophagespecific Bcl-x deficiency
Mice in which exons 1 and 2 of the Bcl-x gene were flanked with loxP sites were crossed with mice expressing Cre recombinase under the control of the lysozyme M gene to generate mice in which Bcl-x was deleted in macrophages. 22, 24, 28 DNA recombination was confirmed in thioglycollate-elicited peritoneal macrophages in which the wild-type allele was almost undetectable. When backcrossed into an Apoe 2/2 background, Bcl-x KO Mac mice exhibited no obvious developmental or morphological abnormalities. To confirm Bcl-x deletion, Bcl-x mRNA levels were measured in BMDM from Bcl-x KO Mac / Apoe 2/2 mice and Apoe 2/2 mice by RT-PCR. mRNA expression of Bcl-x in BMDM of Bcl-x KO Mac mice was 0.002% of that of controls (P0.000001), whereas expression of Bcl-2 was increased 2-fold in Bcl-x KO Mac macrophages (P0.01) ( Figure IA in the online-only Data Supplement). The mRNA levels of the proapoptotic genes Bad, Bax, and Bid were similar in BMDM from Bcl-x KO Mac mice and controls ( Figure  IA in the online-only Data Supplement). Despite upregulation of Bcl-2, BMDM derived from Bcl-x KO Mac /Apoe 2/2 mice were markedly more susceptible either to free-cholesterolor to oxysterol-induced apoptosis when incubated with Ac-LDL and an ACAT inhibitor (P0.01, Figure 1A ) or with 7 ketocholesterol (P0.05, Figure IB in the online-only Data Supplement), respectively, arguing for a pivotal role of Bcl-x in free-cholesterol induced apoptosis. Similarly, freshly harvested peritoneal macrophages and cultured peritoneal and pulmonary macrophages from Bcl-x KO Mac /Apoe 2/2 mice were more susceptible to apoptosis induced by serum starvation as compared to Apoe 2/2 mice ( Figure IB in the online-only Data Supplement). We also evaluated in peritoneal macrophages from both Bcl-x KO Mac /Apoe 2/2 and Apoe 2/2 genotype, the protein levels of Bcl-x and Bcl-2 ( Figure 1B ). The Western blot analysis further demonstrates the lack of Bcl-x protein in Bcl-x KO Mac /Apoe 2/2 versus Apoe 2/2 , whereas Bcl-2 protein levels were unchanged.
In addition, we assessed leukocyte and monocyte subset counts in the different groups of mice maintained under chow diet or cholesterol-rich diet. In female mice fed a chow diet, we found that such cell counts were not altered in Bcl-x KO Mac /Apoe 2/2 mice as compared to wild type Apoe 2/2 mice ( Figure 1C and Figure IIA in the online-only Data Supplement). By contrast, under the cholesterol-rich diet, we observed that the leukocyte count was 30% higher in Bcl-x KO Mac /Apoe 2/2 mice than in Apoe 2/2 mice ( Figure IIA in the online-only Data Supplement). As observed in other studies, the cholesterol-rich diet-induced monocytosis (30% higher in controls) that was more severe in Bcl-x KO Mac /Apoe 2/2 mice (150% higher) and was linked to increase in the Gr1 high monocyte subset (also called Ly-6C high monocytes) ( Figure 1C ). The possibilities of gender differences related to the effect of Bcl-x deficiency were excluded; indeed, a similar leukocyte and monocyte pattern was observed in males ( Figure IIB and IIC in the online-only Data Supplement).
impact of Macrophage-specific Bcl-x deletion on atherogenesis and Cholesterol Levels
Based on our previous observations showing that increased survival of macrophages results in larger early lesions but smaller advanced lesions, we decided to use a complementary strategy and assessed the impact of macrophages more susceptible to stress-induced death on lesion progression. For this purpose, Bcl-x KO Mac /Apoe 2/2 mice and controls were fed cholesterol-enriched diets for 10 (0.15% and 1% cholesterol) or 27 (0.15% cholesterol) weeks. Unexpectedly, we observed higher plasma cholesterol levels in Bcl-x KO Mac /Apoe 2/2 mice compared to Apoe 2/2 controls at all time points and under all diets, including the basal conditions (chow diet fed mice) (Table  and Table I in the online-only Data Supplement). However, after 10 weeks of diet, aortic root lesion area was similar in both Bcl-x KO Mac /Apoe 2/2 mice and controls fed a 0.15% ( Figure  2A and Figure IIIA in the online-only Data Supplement) or a 1% cholesterol-enriched diet ( Figure 2B and Figure IIIB in the online-only Data Supplement). As expected, early lesion area was larger in mice fed a 1% cholesterol-enriched diet compared to those fed a 0.15% cholesterol-enriched diet ( Figure  2A and 2B); 128000 m 2 versus 292000 m 2 in control females (P0.004). As previously reported, 8, 13, 29 no TUNEL 1 cells were present in these early lesions (data not shown). This suggests an efficient removal of apoptotic cells at this stage of the disease. To further validate the potential local depletion of Bcl-x in atherosclerotic lesions, we evaluated the expression of Cre recombinase and of lysozyme M in the whole aorta of Bcl-x KO Mac /Apoe 2/2 and Apoe 2/2 mice fed a Western diet for 10 weeks ( Figure 2C and 2D). Cre recombinase was significantly expressed (ratio of gene expressed by macrophages over reference genes: 0.57 for Cre; 4.4 for ABCG1; 15.7 for SRA) in the aorta of Bcl-x KO Mac /Apoe 2/2 and absent of Apoe 2/2 aortas. Consistent with the local expression of Cre, the expression of Lysozyme M was decreased by 45% in Bcl-x KO Mac /Apoe 2/2 mice versus Apoe 2/2 mice, consistent with a mono-allelic expression due to its heterozygous form in LysM-Cre positive cells. Furthermore, similar levels of mRNA for macrophages markers (CD68, SRA, ABCG1) in both groups of mice ( Figure  2D ) suggested that there were no major changes in the number of macrophages in the lesions. This data indirectly supports the absence of significant differences in lesion size in these males, as already observed in their littermate females ( Figure 2A ) and in male and female groups fed a 1% cholesterol diet for 10 weeks ( Figure 2B ). In addition, quantification of inflammatory genes revealed higher levels of IL-1 mRNA in atherosclerotic lesions of Bcl-x KO Mac /Apoe 2/2 mice versus Apoe 2/2 mice fed a Western diet for 10 weeks (Figure 2E ).
Seventeen additional weeks on a 0.15% cholesterol-enriched diet resulted in larger (10-fold) and more complicated lesions with necrotic core formation. At this time point, en face analysis of the descending aorta showed that lesion areas were 94% larger (P0.006) in females and 25% larger (P0.04) in males in Bcl-x KO Mac /Apoe 2/2 mice relative to controls ( Figure 3A-B) . In contrast to the 10-week time point, the mean area of the aortic root lesion in Bcl-x KO Mac /Apoe 2/2 mice was 27% larger compared to controls after 27 weeks of diet (P0.02, Figure 3C and 3D). Figure 3F ). As macrophages undergoing apoptosis in advanced plaques might likely contribute to necrotic core formation, an index of plaque instability, we measured acellular areas in our animals and observed that the necrotic area was 60% larger in Bcl-x KO Mac /Apoe 2/2 mice compared to controls (P0.0001, Figure 3G ). Collagen content, also indicative of plaque stability, was decreased by 35% in the aortic sinus of Bcl-x KO Mac /Apoe 2/2 compared to Apoe 2/2 control mice (P0.02, Figure 3H and 3I). In males, changes in plaque size ( Figure 2B , Figure 3A ) and in plasma cholesterol ( Table  II in the online-only Data Supplement) following extended periods of Western-type diet feeding were comparable to that observed in females (Figure 2A and Figure 2B , Figure  3A and 3C, and Table I in the online-only Data Supplement) suggesting that the impact of Bcl-x deficiency was not gender specific, as previously reported for macrophage Bcl-2 deficiency in Bcl-2 KO Mac /Apoe 2/2 mice. 22 No significant differences in body weight were observed between genotypes at any time point for both males and females (Table and Table I in the online-only Data Supplement).
impact of Macrophage-specific Bcl-x deletion on Gene expression and Leukocytes in the Liver
To further document mechanisms by which Bcl-x deficiency in macrophages might affect plasma cholesterol levels, we extracted mRNA from liver of mice fed a 0.15% cholesterol (Figure 4 ) or a 1% cholesterol-enriched diet for 10 weeks to perform quantitative RT-PCR. Levels of mRNA for Bcl-x were decreased in the liver of Bcl-x KO Mac /Apoe 2/2 mice as compared to controls but significant changes were only observed in mice fed the 0.15% cholesterol-enriched diet ( Figure 4A and Figure VA in the online-only Data Supplement). As expected, levels of mRNA for Lysozyme M were significantly decreased (239%) in LysM cre/wt /Apoe 2/2 mice as compared to control mice that did not express the Cre recombinase (Bcl-x flox/flox / Apoe 2/2 and Bcl-x wt/wt /Apoe 2/2 mice) reflecting a decrease in Lysosyme M expression due to its heterozygous form in LysM-Cre positive cells. An additional decrease was observed in Bcl-x KO Mac /Apoe 2/2 mice reflecting both the former mechanism and an additional depletion of macrophages expressing Lysosyme M (278%, P0.0001, Figure 4A ). mRNAs encoding for the mononuclear cell markers CD68 and F4/80 were significantly decreased (232% and 224%, respectively) in the liver of Bcl-x KO Mac /Apoe 2/2 mice compared to controls ( Figure 4B) . A similar pattern of expression was observed in mice maintained on 1% cholesterol-enriched diet ( Figure VA in the online-only Data Supplement). We also evaluated the expression of several genes implicated in lipid homeostasis in the liver. As shown in Figure 4C , the expression levels of LDL-R, ABCG1, and SR-A were significantly decreased 229%, 240%, and 229%, respectively) whereas those of ACAT-2, LXRa, ABCA1, and SR-BI were similar in Bcl-x KO Mac /Apoe 2/2 and control mice. A similar pattern of expression was observed in mice maintained on 1% cholesterol-enriched diet ( Figure VB in the online-only Data Supplement). We were also able to demonstrate an ongoing inflammatory process in the liver of Bcl-x KO Mac /Apoe 2/2 mice as there was significant upregulation of MCP-1 mRNA in comparison to controls, indicative of the activation of endothelial cells and macrophages ( Figure 4D ). Flow cytometric analysis revealed that the Küppfer cell population (resident macrophage population of the liver) was significantly reduced (227%, P0.01) in Bcl-x KO Mac /Apoe 2/2 mice compared to controls, whereas the dendritic cell (DC) population was unaffected ( Figure 4E ). Interestingly, a 2.2-fold increase in MHC Class II positive liver leukocytes was observed in Bcl-x KO Mac /Apoe 2/2 mice as compared with controls ( Figure 4E; P0.0003) . We next isolated the Küppfer cells of mice maintained on a Western diet for 10 weeks and quantified inflammatory gene expression ( Figure 4F ). We measured significantly higher levels of IL-1 and a trend to higher levels of IL-18 in Küpffer cells of Bcl-x KO Mac / Apoe 2/2 mice as compared to controls, consistent with the transcriptional profile observed in the whole aorta ( Figure  2E ). In addition, we confirmed expression of the recombinase Cre in Küpffer cells of Bcl-x KO Mac /Apoe 2/2 mice (none detected in controls). This effect was associated with lower expression of Bcl-x ( Figure 4H ) and mono-allelic expression of lysozyme M ( Figure 4G) in Küpffer cells. The levels of other anti-and proapototic genes (Bcl-2, Bid, Bad) were not affected. Interestingly, RNA levels for the LXR responsive gene ABCG1 were increased in Küpffer cells of Bcl-x KO Mac /Apoe 2/2 mice versus controls suggesting accumulation of cholesterol-derived LXR ligands in these cells.
discussion
Given the crucial role of macrophages in the regulation of innate immune responses, the regulation of their life span is critical in both physiological and pathological processes. Macrophage survival depends on multiple pro-and antiapoptotic molecules, among which the antiapoptotic protein Bcl-x is hypothesized to be critically involved in both monocyte/macrophage differentiation and survival, in humans and mice. [18] [19] [20] [21] Our experimental model, in which macrophages specifically lack Bcl-x, further emphasizes the critical involvement of Bcl-x in the protection of macrophages from apoptosis. Indeed, we demonstrated that expression of Bcl-x is almost abolished in BMDM and peritoneal macrophages from Bcl-x KO Mac /Apoe 2/2 mice resulting in poor resistance to apoptotic stress in vitro. In vivo, we noticed a clear depletion of Küpffer cells, the liver resident macrophages, as shown by the reduction in expression of mRNA encoding genes mainly associated with macrophages (LysM, SR-A, ABCG1, CD68, and F4/80) in the liver of Bcl-x KO Mac /Apoe 2/2 mice when compared to controls. Of note, the reduction of Bcl-x expression was not compensated for by major changes in the expression of the antiapoptotic gene Bcl-2 in peritoneal macrophages and Küpffer cells.
Our data clearly show a significant effect of Bcl-x deficiency in macrophages on circulating cholesterol levels of mice maintained on chow-and cholesterol-enriched diets. Interestingly, these observations are consistent with earlier observations in both mice and humans, which also suggest a role for mononuclear phagocytes in cholesterol homeostasis. For example, the hematopoietic growth factor macrophage colony-stimulating factor was reported to lower cholesterol levels in rabbits and nonhuman primate models. 30, 31 At the opposite, op/op mice harboring a mutation in the csf1 gene, which results in a reduction in monocyte and several tissue macrophage populations such as Küpffer cells, 32 present a marked hypercholesterolemia when backcrossed in an Apoe-deficient background. 33 We also previously observed a similar phenotype in CD11 c-DTR Apoe 2/2 mice in which a transient elimination of dendritic cells increased plasma cholesterol levels. 27 Taken together, these observations indicate that mononuclear phagocytes may directly or indirectly influence cholesterol homeostasis. The mechanisms responsible for the increase in total plasma cholesterol levels in Bcl-x KO Mac / Apoe 2/2 mice were not explored in the framework of this study, and the deficiency in ABCG1 mRNA in the liver may likely not contribute to the elevation of circulating cholesterol levels as ABCG1 deficiency in bone marrow derived macrophages was not shown to be associated with enhanced cholesterol levels. 34, 35 The lower expression of ABCG1 mRNA may likely reflect the depletion of Küppfer cells, as it is primarily expressed by these cells in the liver 36 and its expression was not downregulated in purified Küpffer cells.
As macrophage apoptosis has been shown to limit the development of early atherosclerotic lesions, [11] [12] [13] 37, 38 we would have expected a protective effect in early lesions in Bcl-x KO Mac /Apoe 2/2 mice. However, because of a concomitant elevation in plasma cholesterol in Bcl-x KO Mac /Apoe 2/2 mice, the protective effect of increased macrophage death may have been overwhelmed by the hypercholesterolemia observed in these mice. The absence of TUNEL positive cells in the lesions of Bcl-x KO Mac /Apoe 2/2 and control mice may reflect efficient efferocytosis at this stage. 39, 40 Thus, Bcl-x might still play an important role in the control of macrophage survival in early lesions.
In advanced lesions, Bcl-x deficiency in macrophages was associated with larger lesion size in Bcl-x KO Mac /Apoe 2/2 mice as compared to Apoe 2/2 lesions. This finding was associated with a higher frequency of apoptotic cells, a larger necrotic core area and a lower collagen content in the lesions of Bcl-x KO Mac /Apoe 2/2 mice. Interestingly, all these features are indicative of enhanced plaque vulnerability and further support the concept that apoptosis of macrophages favors necrotic core growth. In this model, we cannot distinguish the respective contribution of higher cholesterol levels or of higher susceptibility of macrophages to apoptosis in lesion development in Bcl-x KO Mac /Apoe 2/2 mice during the period of advanced plaque growth. However, irrespective of the contribution of cholesterol levels, which are not always correlated to plaque growth, 41 depletion of macrophages is also ongoing in the latter stages of the disease as we observed lower macrophage content in livers and spleens of 1-year-old
Bcl-x KO Mac /Apoe 2/2 mice as compared to controls (data not shown). These results are consistent with our previous observations indicating that macrophage apoptosis in advanced lesions is proatherogenic. 13 In summary, the present study confirms that macrophage apoptosis appears to be more important in advanced rather than early lesion development, thereby providing a rationale for the association between apoptotic cell accumulation, necrotic core formation, and resulting vulnerable traits. In the quest to identify specific molecular targets and processes that would target the growth of vulnerable lesions, our data suggest that sustaining Bcl-x levels in macrophages would be beneficial both in reducing apoptotic macrophage accumulation in advanced atherosclerotic plaques and maintaining cholesterol homeostasis in the liver, supporting the concept of cross-talk between innate immunity and cholesterol metabolism.
sources of Funding
Andrew I. U. Shearn was supported by a Fellowship from GlaxoSmithKline. This work was supported by an Award to Philippe Lesnik from The Fondation de France. Thierry Huby and Philippe Lesnik gratefully acknowledge the award of a "Contrat d'Interface" by the Assistance Publique, Hôpitaux de Paris/INSERM. Philippe Lesnik gratefully acknowledges financial support provided by Region Ile-de-France CODDIM. disclosures None. 
references
